Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Walgreens CEO Steps Down
Walgreens said its CEO Rosalind Brewer has stepped down and appointed an interim CEO while a search for a replacement is underway.
Load More